vTv Therapeutics Stock Forecast
NASDAQ: VTVTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
VTVT analyst consensus
Consensus (7 analysts)
strong_buy
Avg. price target
$54.71+75.47%
- Strong buy 0
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering vTv Therapeutics (2026-10-09), 7 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $54.71, with a high estimate of $67.00 and a low estimate of $42.00. The average target implies upside of 75.5% from the current price of $31.18.
The spread between the highest and lowest targets is 59.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for VTVT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 7 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $42.00 | +34.70% |
| Average target | $54.71 | +75.47% |
| High target | $67.00 | +114.88% |